FDA's Center for Drug Evaluation and Research director Janet Woodcock told a House Energy and Commerce subcommittee that the drug compounding industry has mutated beyond the limits of the current federal and state regulatory patchwork, as large compounding practices have sparked national bacterial and fungal outbreaks...
To view the full article, take a free trial now.
No comments:
Post a Comment